Analgesic Effect of Infraspinatus-teres Minor Block for Pre-emptive Analgesia in Patients Undergoing Shoulder Surgeries.

Recruiting N/A Interventional Study
Preemptive Analgesia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Zagazig University · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of the study to evaluate the efficacy of the infraspinatus-teres minor (ITM) block in improving pre-emptive analgesia, reducing opioid consumption, and enhancing the overall analgesic effect in patients undergoing shoulder surgeries.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * • Patients' acceptance. * Age: Adults aged 21-65 years old. * BMI: 25-30 kg/m2 * Sex: both sexes (males or females). * Patients undergoing unilateral shoulder surgey under general anesthesia. * ASA (American Society of Anesthesiologists) physical status classificati…
Contacts

Dina Elsadek Salem, MD

01099333513

dinamaghraby@yahoo.com

CONTACT